Articles

The Stop TB Partnership Working Group on New TB Vaccines (WGNV) and the National Institute for Allergy and Infectious Diseases (NIAID)are co-hosting a workshop on the topic of Recognition and Control of Mtb Infected Cells: From Basics to the Clinic. This workshop is intended to address the need for correlates and to identify platforms that measure recognition or control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for Research and Development of New TB Vaccines and the Strategic Framework for New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030. 

The overall goals of this workshop are to: 

• elucidate the mechanisms by which the immune system recognizes the Mtb-infected cell 
• explore the degree to which such recognition can lead to control of the intracellular microbe, and 
• discuss the translational implications of these observations 

The workshop format will be largely discussion-based. Each session will have three short presentations that will provide a high-level overview of key topics within the session theme, followed by a discussion between the session chairs, speakers, and participants. 

Click here to view the programme and speakers. 

This workshop is free of charge and open to any participants interested in this topic. 

The International Society for Infectious Diseases (ISID) and the Swiss Society for Infectious Diseases (SSI) are inviting applications for their joint Infectious Diseases Research Fellowship Program. The purpose of this programme is to support infectious disease physicians and scientists from under-resourced countries through multidisciplinary clinical and laboratory training at a select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID Fellowship programme is open to applicants who are 40 years or younger, citizens and permanent residents of under-resourced countries or Eastern Europe. The deadline for applications is 16 June 2023. 

More information: https://na.eventscloud.com/eSites/748378/Homepage 

The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."  

During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts (Medable) and Leanne Madre (Medable) will present a framework, recommendations, and tools organized around 3 DCT domains: People, Remote Data Collection, and Data Oversight. Best practices for the ethical review, approval, and conduct of DCTs will be provided.   Clinical trial stakeholders (IRB/ECs, HRPP, sites, sponsors, investigators, and others) to register for the webinar here